Sat, December 10, 2011
Lifestyle > Health

Australian scientists find new Alzheimer's vaccine

2011-12-10 06:21:41 GMT2011-12-10 14:21:41(Beijing Time)  Xinhua English

CANBERRA, Dec. 10 (Xinhua) -- Australian scientists from University of Sydney on Saturday announced they have developed a vaccine to help halt the progression of Alzheimer's disease of humans in a joint race.

The vaccine, which targets a damaged protein inside brain's nerve cell known as tau, prevents the ongoing neurofibrillary tangles in the brain of a mouse with Alzheimer's disease. The progress of neurodegenerative condition affects more than 35 million people worldwide.

The research team at the University of Sydney's Brain and Mind Research Institute (BMRI) was led by Associate Professor Lars Ittner, from the Alzheimer's and Parkinson's disease Laboratory.

Professor Ittner said so far the vaccine was only tested in mice with Alzheimer's and results have shown it can stop the disease progressing.

"Our study is the first to show that a vaccine targeting the tau protein can be effective once the disease has already set in," he said in a statement.

"Most of the other vaccines targeting tau were tested only before or around the onset of the disease in animal models, but the vast majority of people with Alzheimer's disease are only diagnosed after the symptoms have appeared."

According to Ittner, his team are working with a major pharmaceutical company on developing the vaccine for human trials within five years.

While none of the vaccines is considered a cure, the team was collaborating with the U.S. pharmaceutical industry to develop this new vaccine and about 269,000 Australians suffering from dementia will therefore be benefited.

Currently, there are some existing drugs can help stop Alzheimer's and other forms of dementia from getting worse. However, they do not tackle the underlying causes and become less effective over time. It estimated over 1 million of Australian will have dementia by 2050.

The scientists published details of study on the vaccine in scientific journal PLoS ONE this week.

| PRINT | RSS

Add Your Comments:

Your Name:
Your Country:
Comment:
(English Only)
 
Please read our Terms of Service. Messages that harass, abuse or threaten others; have obscene or otherwise objectionable content; have spam, commercial or advertising content or links may be removed.

SPECIAL COVERAGE

MOST VIEWED

LATEST VIDEO

PICTURE GALLERY